Page last updated: 2024-11-13

reutericyclin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

reutericyclin: a new tetramic acid related to tenuazonic acid found in sourdough produced by Lactobacillus reuteri LTH2584 exhibits antimicrobial activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54684555
MeSH IDM0373477

Synonyms (13)

Synonym
reutericyclin
303957-69-9
(5r)-1-[(e)-1-oxo-2-decenyl]-3-acetyl-4-hydroxy-5-isobutyl-1h-pyrrole-2(5h)-one
HY-103249
CS-0026201
reutericycline
4XSP5EH6PD
(r)-reutericyclin
3h-pyrrol-3-one, 4-acetyl-1,2-dihydro-5-hydroxy-2-(2-methylpropyl)-1-[(2e)-1-oxo-2-decenyl]-, (2r)-
(2r)-4-acetyl-1-[(e)-dec-2-enoyl]-3-hydroxy-2-(2-methylpropyl)-2h-pyrrol-5-one
MS-25399
(2r)-4-acetyl-1-[(e)-dec-2-enoyl]-5-hydroxy-2-isobutyl-2h-pyrrol-3-one
AKOS040736623

Research Excerpts

Overview

Reutericyclin is a small molecular weight antibiotic produced by the sourdough isolate Lactobacillus reuteri LTH2584. It is structurally but not functionally related to naturally occurring tetramic acids.

ExcerptReferenceRelevance
"Reutericyclin is a unique antimicrobial tetramic acid produced by some strains of Lactobacillus reuteri. "( Genetic determinants of reutericyclin biosynthesis in Lactobacillus reuteri.
Duar, R; Gänzle, M; Lin, XB; Lohans, CT; Vederas, JC; Walter, J; Zheng, J, 2015
)
2.17
"Reutericyclin is a small molecular weight antibiotic produced by the sourdough isolate Lactobacillus reuteri LTH2584. "( Contribution of reutericyclin production to the stable persistence of Lactobacillus reuteri in an industrial sourdough fermentation.
Gänzle, MG; Vogel, RF, 2003
)
2.11
"Reutericyclin is an inhibitory compound produced by sourdough isolates of Lactobacillus reuteri that is structurally but not functionally related to naturally occurring tetramic acids. "( Reutericyclin: biological activity, mode of action, and potential applications.
Gänzle, MG, 2004
)
3.21
"Reutericyclin is a new tetramic acid."( Inhibitory substances produced by Lactobacilli isolated from sourdoughs--a review.
De, VL; Messens, W, 2002
)
1.04

Actions

ExcerptReferenceRelevance
"Reutericyclin did not enhance spore inactivation or DPA release."( Effects of nisin and reutericyclin on resistance of endospores of Clostridium spp. to heat and high pressure.
Gänzle, M; Gebhardt, D; Ho, L; Hofstetter, S; McMullen, LM, 2013
)
1.43

Bioavailability

ExcerptReferenceRelevance
" However, this property varied significantly for the synthetic reutericyclin analogues, ranging from well absorbed to non-absorbed."( Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations.
Heathcott, AE; Hurdle, JG; Lee, RE; Yan, B; Yang, L, 2011
)
2.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (31.82)29.6817
2010's11 (50.00)24.3611
2020's4 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.80 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]